Top compounds associated with response to PTGDR


Feature Type Standardized
Nominal ANOVA
mRNA TAE684 CCLE pan-cancer AAC -0.081 0.06
mRNA PD-0325901 CCLE pan-cancer AAC -0.076 0.06
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.06 0.07
mRNA bendamustine CTRPv2 pan-cancer AAC 0.066 0.07
mRNA AKT inhibitor VIII GDSC1000 pan-cancer AAC 0.06 0.07
mRNA piperlongumine:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.062 0.07
mRNA BAY 61-3606 GDSC1000 pan-cancer AAC 0.059 0.07
mRNA Doxorubicin CTRPv2 pan-cancer AAC 0.052 0.07
mRNA CCT007093 GDSC1000 pan-cancer AAC 0.059 0.08
mRNA Irinotecan CCLE pan-cancer AAC 0.09 0.08
Download CSV